

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.43535185 |
| 2 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.66029972 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.58215156 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.58215156 |
| 5 | protein K11-linked deubiquitination (GO:0035871) | 4.55762323 |
| 6 | T cell migration (GO:0072678) | 4.45070947 |
| 7 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.20693924 |
| 8 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.12846399 |
| 9 | hepatocyte apoptotic process (GO:0097284) | 4.03853251 |
| 10 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 4.01593892 |
| 11 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 4.01593892 |
| 12 | negative regulation of T cell mediated immunity (GO:0002710) | 3.99853040 |
| 13 | face development (GO:0060324) | 3.93653523 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88464107 |
| 15 | establishment of protein localization to Golgi (GO:0072600) | 3.88013209 |
| 16 | protein targeting to Golgi (GO:0000042) | 3.75029593 |
| 17 | natural killer cell activation involved in immune response (GO:0002323) | 3.74610684 |
| 18 | positive regulation of granulocyte differentiation (GO:0030854) | 3.72615151 |
| 19 | histone mRNA catabolic process (GO:0071044) | 3.64782643 |
| 20 | mast cell activation involved in immune response (GO:0002279) | 3.64676873 |
| 21 | mast cell degranulation (GO:0043303) | 3.64676873 |
| 22 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.64314088 |
| 23 | peptidyl-lysine trimethylation (GO:0018023) | 3.51846957 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48947778 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.44497330 |
| 26 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.44497330 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.41326308 |
| 28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.38968704 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37592305 |
| 30 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.36701182 |
| 31 | negative regulation of type 2 immune response (GO:0002829) | 3.34414403 |
| 32 | microglial cell activation (GO:0001774) | 3.28441805 |
| 33 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.27157938 |
| 34 | leukocyte tethering or rolling (GO:0050901) | 3.20462387 |
| 35 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.20315081 |
| 36 | nucleotide transmembrane transport (GO:1901679) | 3.20092351 |
| 37 | histone H3-K36 demethylation (GO:0070544) | 3.19760291 |
| 38 | protein K48-linked deubiquitination (GO:0071108) | 3.19204130 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 3.15457871 |
| 40 | negative regulation of B cell proliferation (GO:0030889) | 3.12428408 |
| 41 | negative T cell selection (GO:0043383) | 3.10614712 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06647749 |
| 43 | negative thymic T cell selection (GO:0045060) | 3.05896408 |
| 44 | negative regulation of adaptive immune response (GO:0002820) | 3.04040504 |
| 45 | response to pheromone (GO:0019236) | 3.03699658 |
| 46 | centriole replication (GO:0007099) | 3.01498971 |
| 47 | mast cell activation (GO:0045576) | 3.00035276 |
| 48 | macroautophagy (GO:0016236) | 2.96619234 |
| 49 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.94439779 |
| 50 | alpha-beta T cell differentiation (GO:0046632) | 2.94132778 |
| 51 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.93992842 |
| 52 | regulation of pigment cell differentiation (GO:0050932) | 2.92683325 |
| 53 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.89066272 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87222046 |
| 55 | histone H3-K9 methylation (GO:0051567) | 2.86737238 |
| 56 | regulation of B cell proliferation (GO:0030888) | 2.86623301 |
| 57 | response to interleukin-15 (GO:0070672) | 2.85209394 |
| 58 | dosage compensation (GO:0007549) | 2.84388368 |
| 59 | histone H3-K9 modification (GO:0061647) | 2.84068437 |
| 60 | response to muramyl dipeptide (GO:0032495) | 2.83971944 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 2.83622091 |
| 62 | cellular response to ethanol (GO:0071361) | 2.81899461 |
| 63 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.81745005 |
| 64 | rRNA catabolic process (GO:0016075) | 2.80413568 |
| 65 | regulation of establishment of cell polarity (GO:2000114) | 2.79879607 |
| 66 | dopamine transport (GO:0015872) | 2.77273309 |
| 67 | response to peptidoglycan (GO:0032494) | 2.76448976 |
| 68 | cellular extravasation (GO:0045123) | 2.74723240 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 2.73988548 |
| 70 | regulation of fibroblast apoptotic process (GO:2000269) | 2.71609372 |
| 71 | positive regulation of B cell proliferation (GO:0030890) | 2.70617018 |
| 72 | microtubule anchoring (GO:0034453) | 2.68099158 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.67653015 |
| 74 | L-fucose catabolic process (GO:0042355) | 2.64410538 |
| 75 | fucose catabolic process (GO:0019317) | 2.64410538 |
| 76 | L-fucose metabolic process (GO:0042354) | 2.64410538 |
| 77 | T-helper cell differentiation (GO:0042093) | 2.63387665 |
| 78 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.63387665 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.63158890 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.61276368 |
| 81 | positive T cell selection (GO:0043368) | 2.60047227 |
| 82 | regulation of DNA endoreduplication (GO:0032875) | 2.59529844 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.58951364 |
| 84 | interkinetic nuclear migration (GO:0022027) | 2.58272540 |
| 85 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57423413 |
| 86 | regulation of interferon-beta production (GO:0032648) | 2.57119217 |
| 87 | alpha-beta T cell activation (GO:0046631) | 2.56859233 |
| 88 | protein K63-linked deubiquitination (GO:0070536) | 2.54951976 |
| 89 | B cell proliferation (GO:0042100) | 2.54483379 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.54396716 |
| 91 | histone-serine phosphorylation (GO:0035404) | 2.53953240 |
| 92 | T cell proliferation (GO:0042098) | 2.52263923 |
| 93 | histone H3-K4 trimethylation (GO:0080182) | 2.52045207 |
| 94 | regulation of protein homodimerization activity (GO:0043496) | 2.51503396 |
| 95 | negative regulation of interleukin-12 production (GO:0032695) | 2.50190480 |
| 96 | interferon-gamma production (GO:0032609) | 2.49366356 |
| 97 | centrosome duplication (GO:0051298) | 2.45588320 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.44424323 |
| 99 | pericardium development (GO:0060039) | 2.44411884 |
| 100 | B cell differentiation (GO:0030183) | 2.43157150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90851754 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36712040 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.19295153 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.03892811 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.01771987 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.96408842 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.84991737 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.78267074 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.77005680 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.57320718 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43000267 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.35417902 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.10053472 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08621664 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02321259 |
| 16 | TP53_16413492_ChIP-PET_HCT116_Human | 2.01513816 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88910422 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85334474 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82884584 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79735265 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75224293 |
| 22 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74075645 |
| 23 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.74075645 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72719539 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71919074 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69460583 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66300753 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65834350 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65450883 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.64256018 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62029166 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61045826 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.55898599 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54086397 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53620308 |
| 36 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50204025 |
| 37 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49984073 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49165643 |
| 39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44775591 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41877232 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40494799 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39534153 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39466756 |
| 44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37980516 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36585722 |
| 46 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.34762591 |
| 47 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34402787 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32453564 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32145263 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30137837 |
| 51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30108393 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30060871 |
| 53 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28949974 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28808143 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.27966223 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24539923 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23791550 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22705927 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21995000 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21715172 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20930486 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19725836 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19088075 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18409495 |
| 65 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17332800 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17112553 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14984227 |
| 68 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14957527 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14430984 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12394402 |
| 71 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11868387 |
| 72 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11739891 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10958923 |
| 74 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10384927 |
| 75 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09199352 |
| 76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06165514 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05323369 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04988810 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04841999 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04778167 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04773372 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04317699 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02576102 |
| 84 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.02562666 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02477651 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02465736 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01677108 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01611710 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01432793 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00222712 |
| 91 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00208024 |
| 92 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.99643552 |
| 93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99516746 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97771641 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96547181 |
| 96 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96482651 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95952263 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95250117 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94166097 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92753294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.90993811 |
| 2 | MP0008057_abnormal_DNA_replication | 3.49700916 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.01814292 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.81703104 |
| 5 | MP0003787_abnormal_imprinting | 2.65603488 |
| 6 | MP0003724_increased_susceptibility_to | 2.58304629 |
| 7 | MP0003303_peritoneal_inflammation | 2.54011999 |
| 8 | MP0000685_abnormal_immune_system | 2.43805662 |
| 9 | MP0002009_preneoplasia | 2.19981159 |
| 10 | MP0001800_abnormal_humoral_immune | 2.19732119 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.13328170 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.06761687 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.03688109 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.00956603 |
| 15 | MP0004381_abnormal_hair_follicle | 1.97090799 |
| 16 | MP0003890_abnormal_embryonic-extraembry | 1.94569949 |
| 17 | MP0004134_abnormal_chest_morphology | 1.92129671 |
| 18 | MP0002398_abnormal_bone_marrow | 1.90016522 |
| 19 | MP0003950_abnormal_plasma_membrane | 1.89025360 |
| 20 | MP0006082_CNS_inflammation | 1.86805735 |
| 21 | MP0002723_abnormal_immune_serum | 1.86705159 |
| 22 | MP0003828_pulmonary_edema | 1.83822554 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.78433043 |
| 24 | MP0005310_abnormal_salivary_gland | 1.75483635 |
| 25 | MP0001819_abnormal_immune_cell | 1.73407802 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 1.68440611 |
| 27 | MP0002419_abnormal_innate_immunity | 1.68027069 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.67753002 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.67105642 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.64730730 |
| 31 | MP0000716_abnormal_immune_system | 1.64220740 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.58500244 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.57641600 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.56524530 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.56261303 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.53815642 |
| 37 | MP0004147_increased_porphyrin_level | 1.52326236 |
| 38 | MP0001873_stomach_inflammation | 1.52126775 |
| 39 | MP0003690_abnormal_glial_cell | 1.49654770 |
| 40 | MP0005387_immune_system_phenotype | 1.45432850 |
| 41 | MP0001790_abnormal_immune_system | 1.45432850 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.44949347 |
| 43 | MP0002722_abnormal_immune_system | 1.43608952 |
| 44 | MP0004883_abnormal_blood_vessel | 1.42700454 |
| 45 | MP0003195_calcinosis | 1.42027235 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.40420791 |
| 47 | MP0002006_tumorigenesis | 1.35974072 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.35444587 |
| 49 | MP0002405_respiratory_system_inflammati | 1.35415889 |
| 50 | MP0006054_spinal_hemorrhage | 1.30476297 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.29684122 |
| 52 | MP0002163_abnormal_gland_morphology | 1.24236674 |
| 53 | MP0002429_abnormal_blood_cell | 1.23624846 |
| 54 | MP0004484_altered_response_of | 1.22288094 |
| 55 | MP0001851_eye_inflammation | 1.20805573 |
| 56 | MP0009764_decreased_sensitivity_to | 1.19725342 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.16869558 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.16869558 |
| 59 | MP0005025_abnormal_response_to | 1.11778009 |
| 60 | MP0003866_abnormal_defecation | 1.10979732 |
| 61 | MP0000427_abnormal_hair_cycle | 1.10582275 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.08582932 |
| 63 | MP0003646_muscle_fatigue | 1.07817409 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.06646174 |
| 65 | MP0003091_abnormal_cell_migration | 1.05514329 |
| 66 | MP0005671_abnormal_response_to | 1.04929189 |
| 67 | MP0004142_abnormal_muscle_tone | 1.04510979 |
| 68 | MP0004947_skin_inflammation | 1.04163050 |
| 69 | MP0005164_abnormal_response_to | 1.04140708 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.01944066 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.00997902 |
| 72 | MP0000371_diluted_coat_color | 1.00961318 |
| 73 | MP0001853_heart_inflammation | 0.95984137 |
| 74 | MP0003300_gastrointestinal_ulcer | 0.92047379 |
| 75 | MP0003436_decreased_susceptibility_to | 0.88877113 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 0.88213794 |
| 77 | MP0001845_abnormal_inflammatory_respons | 0.86499504 |
| 78 | MP0003045_fibrosis | 0.82389871 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.81576795 |
| 80 | MP0001346_abnormal_lacrimal_gland | 0.79865016 |
| 81 | MP0002933_joint_inflammation | 0.79775539 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.78473620 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.77953769 |
| 84 | MP0004130_abnormal_muscle_cell | 0.76646490 |
| 85 | MP0001663_abnormal_digestive_system | 0.75804552 |
| 86 | MP0009278_abnormal_bone_marrow | 0.73800421 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.71922634 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.70921106 |
| 89 | MP0000249_abnormal_blood_vessel | 0.70058085 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.68322327 |
| 91 | MP0009785_altered_susceptibility_to | 0.67231664 |
| 92 | MP0003795_abnormal_bone_structure | 0.66587385 |
| 93 | MP0002160_abnormal_reproductive_system | 0.66323885 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 0.66251485 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.65922928 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.65462401 |
| 97 | MP0005266_abnormal_metabolism | 0.62258218 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 0.61262685 |
| 99 | MP0008873_increased_physiological_sensi | 0.61255028 |
| 100 | MP0005389_reproductive_system_phenotype | 0.60031634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal tarsal ossification (HP:0008369) | 5.34356597 |
| 2 | Abnormal foot bone ossification (HP:0010675) | 4.86148238 |
| 3 | Hypoplastic scapulae (HP:0000882) | 4.40129118 |
| 4 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 4.40129118 |
| 5 | Flat acetabular roof (HP:0003180) | 4.29586355 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.99017490 |
| 7 | T lymphocytopenia (HP:0005403) | 3.93767267 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.73707945 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.73707945 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.69816526 |
| 11 | Spondylolisthesis (HP:0003302) | 3.36827412 |
| 12 | Genetic anticipation (HP:0003743) | 3.09648911 |
| 13 | Slow saccadic eye movements (HP:0000514) | 3.06742976 |
| 14 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.98479997 |
| 15 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.92896129 |
| 16 | Short middle phalanx of the 5th finger (HP:0004220) | 2.92796513 |
| 17 | Abnormality of carpal bone ossification (HP:0006257) | 2.85680289 |
| 18 | Abnormal hand bone ossification (HP:0010660) | 2.81492347 |
| 19 | Recurrent fungal infections (HP:0002841) | 2.71913671 |
| 20 | Hypoplastic iliac wings (HP:0002866) | 2.71344220 |
| 21 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.63492232 |
| 22 | Abnormality of T cells (HP:0002843) | 2.63369317 |
| 23 | Spontaneous hematomas (HP:0007420) | 2.61292209 |
| 24 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.61218809 |
| 25 | Cupped ribs (HP:0000887) | 2.61046907 |
| 26 | Absent frontal sinuses (HP:0002688) | 2.58734462 |
| 27 | Stomach cancer (HP:0012126) | 2.57165651 |
| 28 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.56312908 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.55747924 |
| 30 | Thickened calvaria (HP:0002684) | 2.45520247 |
| 31 | Narrow palate (HP:0000189) | 2.44174924 |
| 32 | Alveolar cell carcinoma (HP:0006519) | 2.42339636 |
| 33 | Hypoplasia of the pons (HP:0012110) | 2.40007446 |
| 34 | Recurrent skin infections (HP:0001581) | 2.37475807 |
| 35 | Viral hepatitis (HP:0006562) | 2.36452813 |
| 36 | Tented upper lip vermilion (HP:0010804) | 2.35930044 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.34028106 |
| 38 | Abnormality of the pons (HP:0007361) | 2.33378329 |
| 39 | Absent speech (HP:0001344) | 2.30823817 |
| 40 | Increased density of long bones (HP:0006392) | 2.30529382 |
| 41 | Chromsome breakage (HP:0040012) | 2.29395649 |
| 42 | Optic neuritis (HP:0100653) | 2.29348290 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.29348290 |
| 44 | Persistence of primary teeth (HP:0006335) | 2.27358385 |
| 45 | Conjunctival telangiectasia (HP:0000524) | 2.25461595 |
| 46 | Spinal cord lesions (HP:0100561) | 2.24374675 |
| 47 | Syringomyelia (HP:0003396) | 2.24374675 |
| 48 | Abnormal ossification of hand bones (HP:0005921) | 2.23843485 |
| 49 | Impulsivity (HP:0100710) | 2.22594783 |
| 50 | Thyroiditis (HP:0100646) | 2.21716253 |
| 51 | Abnormality of the 2nd finger (HP:0004100) | 2.21681683 |
| 52 | Type II lissencephaly (HP:0007260) | 2.19796473 |
| 53 | Tapered finger (HP:0001182) | 2.16262960 |
| 54 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.14513807 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.14345268 |
| 56 | Truncal obesity (HP:0001956) | 2.13778157 |
| 57 | Volvulus (HP:0002580) | 2.11412424 |
| 58 | Neurodegeneration (HP:0002180) | 2.10665826 |
| 59 | Thoracolumbar scoliosis (HP:0002944) | 2.10532422 |
| 60 | Cerebellar dysplasia (HP:0007033) | 2.09822912 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.08877626 |
| 62 | Abnormality of the frontal sinuses (HP:0002687) | 2.08778772 |
| 63 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07724774 |
| 64 | Gingival bleeding (HP:0000225) | 2.07554494 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.04649664 |
| 66 | Hip dysplasia (HP:0001385) | 2.03958666 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.03931036 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.01606954 |
| 69 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.00716064 |
| 70 | Subacute progressive viral hepatitis (HP:0006572) | 2.00677256 |
| 71 | Orchitis (HP:0100796) | 2.00476490 |
| 72 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.00073887 |
| 73 | IgG deficiency (HP:0004315) | 2.00037010 |
| 74 | Abnormality of the parietal bone (HP:0002696) | 1.99131735 |
| 75 | Autoimmune hemolytic anemia (HP:0001890) | 1.98535314 |
| 76 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.97607771 |
| 77 | Short ribs (HP:0000773) | 1.96232024 |
| 78 | Short 5th finger (HP:0009237) | 1.95744717 |
| 79 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.93854600 |
| 80 | Arterial thrombosis (HP:0004420) | 1.92348586 |
| 81 | Neonatal respiratory distress (HP:0002643) | 1.92200687 |
| 82 | Febrile seizures (HP:0002373) | 1.91689842 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 1.90185815 |
| 84 | Neonatal hypoglycemia (HP:0001998) | 1.89126544 |
| 85 | Aqueductal stenosis (HP:0002410) | 1.89110544 |
| 86 | Abnormality of eosinophils (HP:0001879) | 1.87704256 |
| 87 | Acute myeloid leukemia (HP:0004808) | 1.87442629 |
| 88 | Embryonal renal neoplasm (HP:0011794) | 1.87089447 |
| 89 | Abnormality of the prostate (HP:0008775) | 1.86464253 |
| 90 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.85849442 |
| 91 | Abnormality of the wing of the ilium (HP:0011867) | 1.85015502 |
| 92 | Abnormality of the fingertips (HP:0001211) | 1.84951753 |
| 93 | Recurrent viral infections (HP:0004429) | 1.84692105 |
| 94 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.84620880 |
| 95 | Encephalitis (HP:0002383) | 1.84088698 |
| 96 | Large earlobe (HP:0009748) | 1.82425891 |
| 97 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.82369640 |
| 98 | Submucous cleft hard palate (HP:0000176) | 1.82274836 |
| 99 | Microcytic anemia (HP:0001935) | 1.81779718 |
| 100 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.81265742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.23905155 |
| 2 | ACVR1B | 3.00068486 |
| 3 | AKT3 | 2.71514197 |
| 4 | BMPR2 | 2.57554408 |
| 5 | STK38L | 2.50537728 |
| 6 | IRAK1 | 2.41704448 |
| 7 | CDK12 | 2.31712970 |
| 8 | MAP4K1 | 2.24133468 |
| 9 | TAOK3 | 2.12213984 |
| 10 | IKBKE | 2.07222416 |
| 11 | BTK | 1.97499876 |
| 12 | IRAK2 | 1.92648652 |
| 13 | BMPR1B | 1.86860452 |
| 14 | PIK3CG | 1.82515670 |
| 15 | IRAK4 | 1.71793435 |
| 16 | BLK | 1.70592051 |
| 17 | MAP2K3 | 1.70462131 |
| 18 | WEE1 | 1.66007821 |
| 19 | TEC | 1.65324504 |
| 20 | WNK1 | 1.63454331 |
| 21 | TXK | 1.62546322 |
| 22 | MAP3K6 | 1.59280172 |
| 23 | GRK6 | 1.53012749 |
| 24 | BRSK2 | 1.50605156 |
| 25 | CAMK1D | 1.44986187 |
| 26 | TNIK | 1.42864419 |
| 27 | SYK | 1.42668319 |
| 28 | IKBKB | 1.36208475 |
| 29 | MAP4K2 | 1.34587795 |
| 30 | MAP3K14 | 1.34388099 |
| 31 | RIPK4 | 1.33269982 |
| 32 | TRPM7 | 1.30850448 |
| 33 | MAP3K2 | 1.29210306 |
| 34 | FES | 1.24783180 |
| 35 | PIK3CA | 1.24147504 |
| 36 | TGFBR2 | 1.23218448 |
| 37 | GRK5 | 1.21221925 |
| 38 | FGR | 1.20035896 |
| 39 | NLK | 1.09689552 |
| 40 | PIM1 | 1.05191602 |
| 41 | FGFR3 | 1.04783366 |
| 42 | CAMK1G | 1.04033586 |
| 43 | MELK | 1.02624758 |
| 44 | WNK4 | 1.01361669 |
| 45 | STK38 | 0.97288723 |
| 46 | PDK1 | 0.94435830 |
| 47 | STK39 | 0.92746555 |
| 48 | TNK2 | 0.91726848 |
| 49 | STK24 | 0.90372033 |
| 50 | BCR | 0.90270839 |
| 51 | SRPK1 | 0.89715585 |
| 52 | MAP3K7 | 0.88964227 |
| 53 | ADRBK1 | 0.87227113 |
| 54 | CDK9 | 0.86032110 |
| 55 | CAMKK2 | 0.85154908 |
| 56 | HCK | 0.84834346 |
| 57 | PNCK | 0.84236160 |
| 58 | CSF1R | 0.80609241 |
| 59 | CHUK | 0.79453385 |
| 60 | JAK3 | 0.77497974 |
| 61 | SGK2 | 0.75750796 |
| 62 | ITK | 0.75486846 |
| 63 | PTK2B | 0.75100020 |
| 64 | MATK | 0.74378122 |
| 65 | JAK1 | 0.73034357 |
| 66 | MARK3 | 0.73023032 |
| 67 | MAP3K1 | 0.71428333 |
| 68 | MAPKAPK2 | 0.69027099 |
| 69 | JAK2 | 0.66503972 |
| 70 | LRRK2 | 0.66235946 |
| 71 | LYN | 0.62453492 |
| 72 | DYRK3 | 0.62105786 |
| 73 | CSK | 0.61823850 |
| 74 | STK4 | 0.61457278 |
| 75 | ZAP70 | 0.61103176 |
| 76 | LCK | 0.59481988 |
| 77 | STK10 | 0.58949938 |
| 78 | TGFBR1 | 0.58671366 |
| 79 | LATS1 | 0.58101604 |
| 80 | NEK6 | 0.58071400 |
| 81 | RET | 0.55820214 |
| 82 | ERBB2 | 0.54365204 |
| 83 | BRD4 | 0.53960777 |
| 84 | CAMK4 | 0.52508261 |
| 85 | PRPF4B | 0.50726178 |
| 86 | MAP3K11 | 0.50584013 |
| 87 | PRKAA2 | 0.50527507 |
| 88 | STK11 | 0.49852086 |
| 89 | MAP2K4 | 0.49793812 |
| 90 | GRK7 | 0.49544284 |
| 91 | DYRK1A | 0.48449269 |
| 92 | SGK1 | 0.46572957 |
| 93 | PAK3 | 0.46121143 |
| 94 | CCNB1 | 0.45393861 |
| 95 | PRKAA1 | 0.43308546 |
| 96 | TBK1 | 0.43054911 |
| 97 | PRKCQ | 0.41927187 |
| 98 | PKN2 | 0.41823233 |
| 99 | RPS6KB2 | 0.41257820 |
| 100 | GRK1 | 0.40879488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30176156 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.12935727 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09602777 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95263590 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.93667126 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91351453 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89308069 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86465152 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84554159 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.76197741 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.71696098 |
| 12 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.70213142 |
| 13 | Hepatitis B_Homo sapiens_hsa05161 | 1.66934921 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66351706 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62857888 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62231580 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61991627 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52705609 |
| 19 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.46776270 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46292565 |
| 21 | Prostate cancer_Homo sapiens_hsa05215 | 1.43494170 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43374173 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34064369 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33853913 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.32236370 |
| 26 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.27939142 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26717966 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25834132 |
| 29 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24219004 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24125677 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.23643966 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.16135170 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.14699809 |
| 34 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.13847979 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13590723 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13029156 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.12791212 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11547445 |
| 39 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.11166680 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10702511 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10539777 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10031394 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09099762 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08813392 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.07773384 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07510739 |
| 47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.06910960 |
| 48 | Colorectal cancer_Homo sapiens_hsa05210 | 1.05920364 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05713136 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.02766849 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01518300 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93746302 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88291785 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85291042 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84258012 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83474141 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.82584251 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82491166 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82393106 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82140842 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79888979 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78992732 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78680789 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78235977 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76448333 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72400027 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71524509 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70833146 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.70633037 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69503576 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69460383 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68569998 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68050651 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.67828888 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67526668 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67462729 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66008943 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64885264 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.58553752 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.58518287 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58106441 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54516666 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53383006 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51509968 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50578029 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50572900 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.50556601 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49925967 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49616456 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.49132252 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49010292 |
| 92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49008289 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48054453 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47032717 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46457781 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46009634 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45964596 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.44968565 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42099250 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41906907 |

